Artemia is a brine shrimp genus adapted to extreme habitats like ranges salinity from 5-25 g/L and in temperatures from 9 to 35 °C. It is widely distributed and used as an environmental quality biomarker. Artemia franciscana and Artemia salina species are commonly used in ecotoxicological studies and genotoxicity assays due to their short life cycle, high fecundity rate, easy culture, and availability. Thus, considering the importance of these tests in ecotoxicological studies, the present study aimed to present Artemia genus as a biological model in genotoxicity research. To this end, we reviewed the literature, analyzing data published until July 2023 in the Web of Science, SCOPUS, Embase, and PubMed databases. After screening, we selected 34 studies in which the genotoxicity of Artemia for various substances. This review presents the variability of the experimental planning of assays and biomarkers in genotoxicity using Artemia genus as a biological model for ecotoxicological studies and show the possibility of monitoring biochemical alterations and genetic damage effects. Also highlight innovative technologies such as transcriptomic and metabolomic analysis, as well as studies over successive generations to identify changes in DNA and consequently in gene expression.
Antiretrovirals (ARVs) have become one of the most prescribed groups of drugs, and these residues are found in the environment. Among them, the most widely used in HIV treatment are tenofovir (TDF), lamivudine (3TC), and dolutegravir (DTG). This study aimed to evaluate the toxicity of ARVs TDF, 3TC, and DTG on the cyanobacterium Microcystis novacekii and estimate their environmental risk. DTG showed the highest toxicity among the drugs tested, inhibiting cyanobacteria cell growth and metabolic activity at low concentrations. TDF and 3TC alone were less toxic, with more pronounced adverse effects in long time exposures at high concentrations. However, the combination of ARVs, especially TDF and 3TC, showed a synergistic effect, significantly increasing toxicity compared to the drugs alone. Excipients found in commercial formulations of ARVs, such as sodium lauryl sulfate, also influenced toxicity. Although DTG showed the highest risk to cyanobacteria, the environmental risk assessment indicated that TDF and 3TC, although less toxic to M. novacekii, may pose moderate-to-high environmental risks at typical environmental concentrations. These results reinforce the need for strict regulation and monitoring of the release of ARVs into the environment, and the development of effective treatments for removing these residues in sewage treatment plants. This study contributes to understanding the ecotoxicological impacts of ARVs and highlights the importance of long-term assessments to adequately estimate the environmental risks of ARVs and their commercial formulations.
Antiretrovirals (ARVs) present variable toxicity to aquatic organisms. This study reviewed the literature from the Web of Science, Scopus, and PubMed to evaluate ARV ecotoxicity, focusing on aquatic models. Inclusion criteria were studies using ARVs as test substances with toxicity data on aquatic organisms. Quality assessment followed the CRED method, and environmental risk was evaluated via risk quotients (RQs) using the ERA tool. Efavirenz emerged as the most toxic ARV, with EC50 values of 0.011 mg/L (Chlorococcum infusionum) to 0.034 mg/L (Raphidocelis subcapitata), causing growth inhibition, photosynthesis reduction, and oxidative stress. Tenofovir showed lower toxicity, with EC50 values above 300.0 mg/L (Biomphalaria glabrata) and 111.82 mg/L (Artemia salina). Other ARVs, including Lamivudine and Zidovudine, displayed moderate toxicity (EC50 3.013–5.442 mg/L in microalgae). Main effects observed included oxidative damage, altered enzyme activity (catalase and NADH-cytochrome C oxidoreductase), reduced growth and photosynthesis, and bioaccumulation in aquatic plants like Lemna minor. Efavirenz also showed synergistic toxicity when combined with other ARVs. These findings indicate that ARVs, particularly highly toxic compounds such as Efavirenz, pose significant ecological risks, emphasizing the importance of proper disposal and remediation strategies to protect aquatic ecosystems.
Objective: To estimate the consumption and quantity of unaltered antiretrivirals (ARV) eliminated into the environment and to carry out a literature research on aquatic ecotoxicological studies of ARV used in Brazil. Methodology: We requested from one of the ARV dispensing units in the city of Belo-Horizonte (BH) the amount of ARV dispensed in the years 2018-2019-2020. Considering the amount dispensed in 2020, the daily dose, and the elimination rate, the amount of drug in unchanged form in the environment was estimated. For entire municipality of BH and Brazil, we used epidemiological data were used regarding individuals using antiretroviral therapy (ART) in 2020, the proportion of people living with HIV using the main ART regimen, following the same estimation methodology used previously. Structured and individual searches were carried out for each ARV used in Brazil, relating it to ecotoxicology, through Google Scholar, National Center for Biotechnology Information and Scifinder, in addition to the use of the fass.se platform. Results: Four articles presented results of acute or chronic toxicity in ecotoxicological models involving ARV. Dolutegravir and efavirenz were found to be highly toxic in ecotoxicological models. In 2020, approximately 2,167kg of ARVs in unchanged form were released into the environment in BH. In Brazil it was 112,274kg. Conclusion: It is urgent to quantify the main ARV in water bodies. With these data together with ecotoxicological data it will be possible to establish risk criteria for possible measures to control or mitigate these contaminants in the environment, especially actions to improve wastewater/water treatment.
4 December 2021 in Research, Society and Development
Goal: To assess body mass index (BMI) changes in people living with HIV (PLHIV) and using antiretroviral therapy (ART) with dolutegravir (DTG) and its associated factors. Methods: Retrospective and prospective cohorts of PLHIV who started ART with DTG or used DTG after changing the therapeutic regimen, from Belo Horizonte, between February/2017 and March/2020. Data were gathered from clinical records of the Drug Logistics and Laboratory Test Control Systems. BMI changes were analyzed in the following week intervals 1-24(t24), 25-48(t48), 49-72(t73), and 73-96(t96) using the Wilcoxon test and generalized estimation equation (GEE) model, at 5% significance level. Results: A total of 614 individuals were included and average was 38.4 years old. Most were men (85.5%) and 52.3% had started ART with DTG. These individuals, and the immunosuppressed ones, showed significant increases in BMI when compared to those who used DTG after switching therapeutics or the non-immunosuppressed ones (p-value <0.05). After 96 weeks, individuals starting ART with DTG had a mean increase in BMI of 1.02 Kg/m2, whereas those who used DTG after the therapeutic change had an increase of 0.56 Kg/m2 (p<0.05). DTG use length, ART type, immune status, baseline BMI, and age were associated (p<0.05) with BMI increases. Conclusions: We observed an increase in BMI both in individuals starting ART with DTG use and those using it after changing the therapeutic regimen.
The worldwide consumption of medicines has increased exponentially with a consequent increase of these pollutants in the environment. This study aimed to evaluate the ecotoxicity of entecavir (ETV), an antiviral used to treat hepatitis B, in models of Aliivibrio fischeri, Microcystis novacekii, Artemia salina, and Biomphalaria glabrata, which directly interferes with enzymatic processes and protein synthesis, possibly impacting the environment and human health. In the ecotoxicological tests, the organisms were exposed to ETV concentrations ranging from 0 to 300 mg/L at 30 min to 96 h intervals, depending on the model used. Only toxicity results at concentrations below 100 mg/L were considered environmentally relevant. Statistical analyses for the A. salina, M. novacekii, and B. glabrata models were conducted using dose–response regressions. Mortality in the B. glabrata model was assessed using the Kruskal–Wallis test. For the model with A. fischeri, the analyses were performed considering the mean bioluminescence values against the control (sample without ETV) on a logarithmic scale with the R2 determination index as the reference for the fit under the standard Microtox procedure. A significance level of 5% was adopted for all analyses. None of the biological models exposed to ETV showed toxicity at environmentally relevant concentrations (<100 mg/L). Although it may seem that ETV does not pose a risk to the environment due to its low ecotoxicological spectrum, given the lack of toxicity observed in the models tested and the nondetection of ETV in the environment, the rational use, disposal, treatment, and final disposal of pharmaceutical waste of this drug, the monitoring of pharmaceutical waste in sewage and water treatment systems and the improvement of these systems should be encouraged to mitigate possible environmental, economic, and health impacts.